INTERSTITIAL LUNG DISEASE

Adverse reaction reported in 11,890 FDA reports across 17 drugs.

11,890
Total Reports
17
Drugs Involved
Pembrolizumab
Most Reported Drug

Drugs Associated with INTERSTITIAL LUNG DISEASE

Drugs where "INTERSTITIAL LUNG DISEASE" was reported as an adverse event.

# Drug Reports % of Total
1 Pembrolizumab 2,434
20.5%
2 Nivolumab 1,614
13.6%
3 Fam-Trastuzumab Deruxtecan-Nxki 982
8.3%
4 Pemetrexed Disodium 884
7.4%
5 Atezolizumab 810
6.8%
6 Vincristine 680
5.7%
7 Lenvatinib 651
5.5%
8 Osimertinib 579
4.9%
9 Durvalumab 464
3.9%
10 Pemetrexed 427
3.6%
11 Gefitinib 420
3.5%
12 Olaparib 378
3.2%
13 Panitumumab 375
3.2%
14 Bicalutamide 365
3.1%
15 Abemaciclib 354
3.0%
16 Daptomycin 251
2.1%
17 Bleomycin 222
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused interstitial lung disease. Always consult your healthcare provider.